Alcon Inc.
Alcon Inc. ALC Peers
See (ALC) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ALC | $88.31 | +0.84% | 43.1B | 38.72 | $2.25 | +0.38% |
| ISRG | $542.15 | +3.93% | 191.5B | 78.24 | $6.83 | N/A |
| BDXA | $59.24 | -2.24% | 49.5B | 21.44 | $2.76 | +2.40% |
| BDX | $171.43 | +0.31% | 48.7B | 32.94 | $5.16 | +2.40% |
| RMD | $255.65 | -0.88% | 37.6B | 28.76 | $8.91 | +0.83% |
| WST | $219.67 | -0.61% | 15.7B | 34.44 | $6.36 | +0.38% |
| BAX | $30.45 | -0.52% | 15.7B | -58.67 | -$0.52 | +2.63% |
| HOLX | $65.49 | +1.91% | 14.5B | 27.36 | $2.38 | N/A |
| COO | $71.63 | +3.00% | 13.9B | 33.67 | $2.07 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.40% |
Stock Comparison
ALC vs ISRG Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, ISRG has a market cap of 191.5B. Regarding current trading prices, ALC is priced at $88.31, while ISRG trades at $542.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas ISRG's P/E ratio is 78.24. In terms of profitability, ALC's ROE is +0.07%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, ALC is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs BDXA Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, BDXA has a market cap of 49.5B. Regarding current trading prices, ALC is priced at $88.31, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas BDXA's P/E ratio is 21.44. In terms of profitability, ALC's ROE is +0.07%, compared to BDXA's ROE of +0.06%. Regarding short-term risk, ALC is less volatile compared to BDXA. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs BDX Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, BDX has a market cap of 48.7B. Regarding current trading prices, ALC is priced at $88.31, while BDX trades at $171.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas BDX's P/E ratio is 32.94. In terms of profitability, ALC's ROE is +0.07%, compared to BDX's ROE of +0.06%. Regarding short-term risk, ALC is more volatile compared to BDX. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs RMD Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, RMD has a market cap of 37.6B. Regarding current trading prices, ALC is priced at $88.31, while RMD trades at $255.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas RMD's P/E ratio is 28.76. In terms of profitability, ALC's ROE is +0.07%, compared to RMD's ROE of +0.25%. Regarding short-term risk, ALC is less volatile compared to RMD. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs WST Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, WST has a market cap of 15.7B. Regarding current trading prices, ALC is priced at $88.31, while WST trades at $219.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas WST's P/E ratio is 34.44. In terms of profitability, ALC's ROE is +0.07%, compared to WST's ROE of +0.17%. Regarding short-term risk, ALC is less volatile compared to WST. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs BAX Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, BAX has a market cap of 15.7B. Regarding current trading prices, ALC is priced at $88.31, while BAX trades at $30.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas BAX's P/E ratio is -58.67. In terms of profitability, ALC's ROE is +0.07%, compared to BAX's ROE of -0.08%. Regarding short-term risk, ALC is more volatile compared to BAX. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs HOLX Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, HOLX has a market cap of 14.5B. Regarding current trading prices, ALC is priced at $88.31, while HOLX trades at $65.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas HOLX's P/E ratio is 27.36. In terms of profitability, ALC's ROE is +0.07%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, ALC is less volatile compared to HOLX. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs COO Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, COO has a market cap of 13.9B. Regarding current trading prices, ALC is priced at $88.31, while COO trades at $71.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas COO's P/E ratio is 33.67. In terms of profitability, ALC's ROE is +0.07%, compared to COO's ROE of +0.05%. Regarding short-term risk, ALC is less volatile compared to COO. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs BDXB Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, ALC is priced at $88.31, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas BDXB's P/E ratio is 7.60. In terms of profitability, ALC's ROE is +0.07%, compared to BDXB's ROE of +0.06%. Regarding short-term risk, ALC is less volatile compared to BDXB. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs ATR Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, ATR has a market cap of 10.2B. Regarding current trading prices, ALC is priced at $88.31, while ATR trades at $155.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas ATR's P/E ratio is 28.24. In terms of profitability, ALC's ROE is +0.07%, compared to ATR's ROE of +0.15%. Regarding short-term risk, ALC is more volatile compared to ATR. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs MASI Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, MASI has a market cap of 9B. Regarding current trading prices, ALC is priced at $88.31, while MASI trades at $166.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas MASI's P/E ratio is -30.48. In terms of profitability, ALC's ROE is +0.07%, compared to MASI's ROE of -0.41%. Regarding short-term risk, ALC is less volatile compared to MASI. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs RGEN Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, RGEN has a market cap of 7B. Regarding current trading prices, ALC is priced at $88.31, while RGEN trades at $124.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas RGEN's P/E ratio is -295.74. In terms of profitability, ALC's ROE is +0.07%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, ALC is less volatile compared to RGEN. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs STVN Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, STVN has a market cap of 6.9B. Regarding current trading prices, ALC is priced at $88.31, while STVN trades at $24.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas STVN's P/E ratio is 47.44. In terms of profitability, ALC's ROE is +0.07%, compared to STVN's ROE of +0.09%. Regarding short-term risk, ALC is less volatile compared to STVN. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs MMSI Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, MMSI has a market cap of 5.5B. Regarding current trading prices, ALC is priced at $88.31, while MMSI trades at $93.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas MMSI's P/E ratio is 45.49. In terms of profitability, ALC's ROE is +0.07%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, ALC and MMSI have similar daily volatility (1.36).
ALC vs TFX Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, TFX has a market cap of 5.3B. Regarding current trading prices, ALC is priced at $88.31, while TFX trades at $119.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas TFX's P/E ratio is 37.00. In terms of profitability, ALC's ROE is +0.07%, compared to TFX's ROE of +0.03%. Regarding short-term risk, ALC is more volatile compared to TFX. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs BLCO Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, BLCO has a market cap of 4.3B. Regarding current trading prices, ALC is priced at $88.31, while BLCO trades at $12.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas BLCO's P/E ratio is -11.83. In terms of profitability, ALC's ROE is +0.07%, compared to BLCO's ROE of -0.08%. Regarding short-term risk, ALC is less volatile compared to BLCO. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs HAE Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, ALC is priced at $88.31, while HAE trades at $74.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas HAE's P/E ratio is 22.61. In terms of profitability, ALC's ROE is +0.07%, compared to HAE's ROE of +0.18%. Regarding short-term risk, ALC is less volatile compared to HAE. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs ICUI Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, ICUI has a market cap of 3.2B. Regarding current trading prices, ALC is priced at $88.31, while ICUI trades at $131.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas ICUI's P/E ratio is -34.10. In terms of profitability, ALC's ROE is +0.07%, compared to ICUI's ROE of -0.05%. Regarding short-term risk, ALC is less volatile compared to ICUI. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs XRAY Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, XRAY has a market cap of 3.2B. Regarding current trading prices, ALC is priced at $88.31, while XRAY trades at $15.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas XRAY's P/E ratio is -3.58. In terms of profitability, ALC's ROE is +0.07%, compared to XRAY's ROE of -0.38%. Regarding short-term risk, ALC is less volatile compared to XRAY. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs WRBY Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, WRBY has a market cap of 2.6B. Regarding current trading prices, ALC is priced at $88.31, while WRBY trades at $21.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas WRBY's P/E ratio is -178.92. In terms of profitability, ALC's ROE is +0.07%, compared to WRBY's ROE of -0.04%. Regarding short-term risk, ALC is less volatile compared to WRBY. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs QDEL Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, QDEL has a market cap of 1.9B. Regarding current trading prices, ALC is priced at $88.31, while QDEL trades at $28.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas QDEL's P/E ratio is -5.49. In terms of profitability, ALC's ROE is +0.07%, compared to QDEL's ROE of -0.11%. Regarding short-term risk, ALC is less volatile compared to QDEL. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs NVCR Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, ALC is priced at $88.31, while NVCR trades at $17.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas NVCR's P/E ratio is -11.32. In terms of profitability, ALC's ROE is +0.07%, compared to NVCR's ROE of -0.45%. Regarding short-term risk, ALC is less volatile compared to NVCR. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs LMAT Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, ALC is priced at $88.31, while LMAT trades at $83.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas LMAT's P/E ratio is 41.83. In terms of profitability, ALC's ROE is +0.07%, compared to LMAT's ROE of +0.14%. Regarding short-term risk, ALC is less volatile compared to LMAT. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs ATRC Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, ATRC has a market cap of 1.6B. Regarding current trading prices, ALC is priced at $88.31, while ATRC trades at $32.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas ATRC's P/E ratio is -40.59. In terms of profitability, ALC's ROE is +0.07%, compared to ATRC's ROE of -0.08%. Regarding short-term risk, ALC is less volatile compared to ATRC. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs NNNN Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, NNNN has a market cap of 1.5B. Regarding current trading prices, ALC is priced at $88.31, while NNNN trades at $31.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas NNNN's P/E ratio is 672.80. In terms of profitability, ALC's ROE is +0.07%, compared to NNNN's ROE of +0.14%. Regarding short-term risk, ALC is less volatile compared to NNNN. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs AZTA Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, AZTA has a market cap of 1.4B. Regarding current trading prices, ALC is priced at $88.31, while AZTA trades at $29.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas AZTA's P/E ratio is -9.41. In terms of profitability, ALC's ROE is +0.07%, compared to AZTA's ROE of -0.04%. Regarding short-term risk, ALC is less volatile compared to AZTA. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs BLFS Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, BLFS has a market cap of 1B. Regarding current trading prices, ALC is priced at $88.31, while BLFS trades at $21.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas BLFS's P/E ratio is -113.05. In terms of profitability, ALC's ROE is +0.07%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, ALC is less volatile compared to BLFS. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs PLSE Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, PLSE has a market cap of 1B. Regarding current trading prices, ALC is priced at $88.31, while PLSE trades at $15.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas PLSE's P/E ratio is -15.04. In terms of profitability, ALC's ROE is +0.07%, compared to PLSE's ROE of -0.71%. Regarding short-term risk, ALC is less volatile compared to PLSE. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs KMTS Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, KMTS has a market cap of 919.1M. Regarding current trading prices, ALC is priced at $88.31, while KMTS trades at $17.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas KMTS's P/E ratio is -9.32. In terms of profitability, ALC's ROE is +0.07%, compared to KMTS's ROE of +0.27%. Regarding short-term risk, ALC is less volatile compared to KMTS. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs STAA Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, STAA has a market cap of 833.5M. Regarding current trading prices, ALC is priced at $88.31, while STAA trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas STAA's P/E ratio is -11.69. In terms of profitability, ALC's ROE is +0.07%, compared to STAA's ROE of -0.18%. Regarding short-term risk, ALC is less volatile compared to STAA. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs ATRI Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, ALC is priced at $88.31, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas ATRI's P/E ratio is 64.50. In terms of profitability, ALC's ROE is +0.07%, compared to ATRI's ROE of +0.04%. Regarding short-term risk, ALC is more volatile compared to ATRI. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs ANGO Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, ANGO has a market cap of 400.8M. Regarding current trading prices, ALC is priced at $88.31, while ANGO trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas ANGO's P/E ratio is -9.77. In terms of profitability, ALC's ROE is +0.07%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, ALC is less volatile compared to ANGO. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs NYXH Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, NYXH has a market cap of 287.5M. Regarding current trading prices, ALC is priced at $88.31, while NYXH trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas NYXH's P/E ratio is -3.34. In terms of profitability, ALC's ROE is +0.07%, compared to NYXH's ROE of -0.56%. Regarding short-term risk, ALC is less volatile compared to NYXH. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs SMTI Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, SMTI has a market cap of 252.1M. Regarding current trading prices, ALC is priced at $88.31, while SMTI trades at $28.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas SMTI's P/E ratio is -21.16. In terms of profitability, ALC's ROE is +0.07%, compared to SMTI's ROE of -0.29%. Regarding short-term risk, ALC is less volatile compared to SMTI. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs OSUR Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, OSUR has a market cap of 225.9M. Regarding current trading prices, ALC is priced at $88.31, while OSUR trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas OSUR's P/E ratio is -7.19. In terms of profitability, ALC's ROE is +0.07%, compared to OSUR's ROE of -0.08%. Regarding short-term risk, ALC is less volatile compared to OSUR. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs STXS Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, STXS has a market cap of 188.3M. Regarding current trading prices, ALC is priced at $88.31, while STXS trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas STXS's P/E ratio is -7.06. In terms of profitability, ALC's ROE is +0.07%, compared to STXS's ROE of -2.17%. Regarding short-term risk, ALC is less volatile compared to STXS. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs UTMD Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, UTMD has a market cap of 183.3M. Regarding current trading prices, ALC is priced at $88.31, while UTMD trades at $56.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas UTMD's P/E ratio is 14.89. In terms of profitability, ALC's ROE is +0.07%, compared to UTMD's ROE of +0.11%. Regarding short-term risk, ALC is more volatile compared to UTMD. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs KRMD Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, KRMD has a market cap of 165.2M. Regarding current trading prices, ALC is priced at $88.31, while KRMD trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas KRMD's P/E ratio is -29.83. In terms of profitability, ALC's ROE is +0.07%, compared to KRMD's ROE of -0.30%. Regarding short-term risk, ALC is less volatile compared to KRMD. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs PDEX Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, PDEX has a market cap of 140.6M. Regarding current trading prices, ALC is priced at $88.31, while PDEX trades at $44.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas PDEX's P/E ratio is 15.62. In terms of profitability, ALC's ROE is +0.07%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, ALC is less volatile compared to PDEX. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs ZTEK Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, ZTEK has a market cap of 137.2M. Regarding current trading prices, ALC is priced at $88.31, while ZTEK trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas ZTEK's P/E ratio is -16.44. In terms of profitability, ALC's ROE is +0.07%, compared to ZTEK's ROE of -0.58%. Regarding short-term risk, ALC is less volatile compared to ZTEK. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs INFU Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, INFU has a market cap of 134.9M. Regarding current trading prices, ALC is priced at $88.31, while INFU trades at $6.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas INFU's P/E ratio is 42.87. In terms of profitability, ALC's ROE is +0.07%, compared to INFU's ROE of +0.08%. Regarding short-term risk, ALC is less volatile compared to INFU. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs ZJYL Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, ZJYL has a market cap of 102.3M. Regarding current trading prices, ALC is priced at $88.31, while ZJYL trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas ZJYL's P/E ratio is 32.68. In terms of profitability, ALC's ROE is +0.07%, compared to ZJYL's ROE of +0.13%. Regarding short-term risk, ALC is less volatile compared to ZJYL. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs MBOT Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, MBOT has a market cap of 90.9M. Regarding current trading prices, ALC is priced at $88.31, while MBOT trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas MBOT's P/E ratio is -3.91. In terms of profitability, ALC's ROE is +0.07%, compared to MBOT's ROE of -0.85%. Regarding short-term risk, ALC is less volatile compared to MBOT. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs AKYA Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, AKYA has a market cap of 66.2M. Regarding current trading prices, ALC is priced at $88.31, while AKYA trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas AKYA's P/E ratio is -1.38. In terms of profitability, ALC's ROE is +0.07%, compared to AKYA's ROE of -5.06%. Regarding short-term risk, ALC is less volatile compared to AKYA. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs MLSS Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, MLSS has a market cap of 56.8M. Regarding current trading prices, ALC is priced at $88.31, while MLSS trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas MLSS's P/E ratio is -12.07. In terms of profitability, ALC's ROE is +0.07%, compared to MLSS's ROE of -0.83%. Regarding short-term risk, ALC is less volatile compared to MLSS. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs OMIC Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, ALC is priced at $88.31, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas OMIC's P/E ratio is -0.58. In terms of profitability, ALC's ROE is +0.07%, compared to OMIC's ROE of -0.58%. Regarding short-term risk, ALC is more volatile compared to OMIC. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs IGAP Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, ALC is priced at $88.31, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas IGAP's P/E ratio is -10.52. In terms of profitability, ALC's ROE is +0.07%, compared to IGAP's ROE of +3.93%. Regarding short-term risk, ALC is less volatile compared to IGAP. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs DXR Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, DXR has a market cap of 48.2M. Regarding current trading prices, ALC is priced at $88.31, while DXR trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas DXR's P/E ratio is -108.00. In terms of profitability, ALC's ROE is +0.07%, compared to DXR's ROE of +0.02%. Regarding short-term risk, ALC is less volatile compared to DXR. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs NEPH Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, NEPH has a market cap of 44.9M. Regarding current trading prices, ALC is priced at $88.31, while NEPH trades at $3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas NEPH's P/E ratio is 53.00. In terms of profitability, ALC's ROE is +0.07%, compared to NEPH's ROE of +0.09%. Regarding short-term risk, ALC is less volatile compared to NEPH. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs POCI Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, POCI has a market cap of 35M. Regarding current trading prices, ALC is priced at $88.31, while POCI trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas POCI's P/E ratio is -5.02. In terms of profitability, ALC's ROE is +0.07%, compared to POCI's ROE of -0.54%. Regarding short-term risk, ALC is less volatile compared to POCI. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs SDC Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, ALC is priced at $88.31, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas SDC's P/E ratio is -0.03. In terms of profitability, ALC's ROE is +0.07%, compared to SDC's ROE of -1.96%. Regarding short-term risk, ALC is less volatile compared to SDC. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs FEMY Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, FEMY has a market cap of 28.7M. Regarding current trading prices, ALC is priced at $88.31, while FEMY trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas FEMY's P/E ratio is -1.08. In terms of profitability, ALC's ROE is +0.07%, compared to FEMY's ROE of -3.92%. Regarding short-term risk, ALC is less volatile compared to FEMY. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs IVC Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, ALC is priced at $88.31, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas IVC's P/E ratio is -0.79. In terms of profitability, ALC's ROE is +0.07%, compared to IVC's ROE of -0.46%. Regarding short-term risk, ALC is less volatile compared to IVC. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs HBIO Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, HBIO has a market cap of 22.6M. Regarding current trading prices, ALC is priced at $88.31, while HBIO trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas HBIO's P/E ratio is -0.39. In terms of profitability, ALC's ROE is +0.07%, compared to HBIO's ROE of -1.10%. Regarding short-term risk, ALC is less volatile compared to HBIO. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs RVP Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, RVP has a market cap of 19.8M. Regarding current trading prices, ALC is priced at $88.31, while RVP trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas RVP's P/E ratio is -0.87. In terms of profitability, ALC's ROE is +0.07%, compared to RVP's ROE of -0.27%. Regarding short-term risk, ALC is less volatile compared to RVP. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs WOK Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, WOK has a market cap of 18.4M. Regarding current trading prices, ALC is priced at $88.31, while WOK trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas WOK's P/E ratio is -2.74. In terms of profitability, ALC's ROE is +0.07%, compared to WOK's ROE of -0.30%. Regarding short-term risk, ALC is less volatile compared to WOK. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs NXGL Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, NXGL has a market cap of 18.4M. Regarding current trading prices, ALC is priced at $88.31, while NXGL trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas NXGL's P/E ratio is -5.33. In terms of profitability, ALC's ROE is +0.07%, compared to NXGL's ROE of -0.63%. Regarding short-term risk, ALC is less volatile compared to NXGL. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs NXGLW Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, NXGLW has a market cap of 17.1M. Regarding current trading prices, ALC is priced at $88.31, while NXGLW trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas NXGLW's P/E ratio is -0.19. In terms of profitability, ALC's ROE is +0.07%, compared to NXGLW's ROE of -0.63%. Regarding short-term risk, ALC is less volatile compared to NXGLW. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs MHUA Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, MHUA has a market cap of 13.9M. Regarding current trading prices, ALC is priced at $88.31, while MHUA trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas MHUA's P/E ratio is 1.10. In terms of profitability, ALC's ROE is +0.07%, compared to MHUA's ROE of +0.09%. Regarding short-term risk, ALC is less volatile compared to MHUA. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs LUCYW Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, LUCYW has a market cap of 13.8M. Regarding current trading prices, ALC is priced at $88.31, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas LUCYW's P/E ratio is N/A. In terms of profitability, ALC's ROE is +0.07%, compared to LUCYW's ROE of -0.95%. Regarding short-term risk, ALC is less volatile compared to LUCYW. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs EKSO Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, EKSO has a market cap of 8.6M. Regarding current trading prices, ALC is priced at $88.31, while EKSO trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas EKSO's P/E ratio is -0.50. In terms of profitability, ALC's ROE is +0.07%, compared to EKSO's ROE of -0.82%. Regarding short-term risk, ALC is less volatile compared to EKSO. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs POAI Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, POAI has a market cap of 7.7M. Regarding current trading prices, ALC is priced at $88.31, while POAI trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas POAI's P/E ratio is -0.60. In terms of profitability, ALC's ROE is +0.07%, compared to POAI's ROE of -5.91%. Regarding short-term risk, ALC is less volatile compared to POAI. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs LUCY Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, LUCY has a market cap of 6.3M. Regarding current trading prices, ALC is priced at $88.31, while LUCY trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas LUCY's P/E ratio is 0.04. In terms of profitability, ALC's ROE is +0.07%, compared to LUCY's ROE of -0.95%. Regarding short-term risk, ALC is less volatile compared to LUCY. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs STSS Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, STSS has a market cap of 5.6M. Regarding current trading prices, ALC is priced at $88.31, while STSS trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas STSS's P/E ratio is N/A. In terms of profitability, ALC's ROE is +0.07%, compared to STSS's ROE of -0.99%. Regarding short-term risk, ALC is less volatile compared to STSS. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs NSTG Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, ALC is priced at $88.31, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas NSTG's P/E ratio is -0.03. In terms of profitability, ALC's ROE is +0.07%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, ALC is less volatile compared to NSTG. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs GCTK Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, GCTK has a market cap of 3M. Regarding current trading prices, ALC is priced at $88.31, while GCTK trades at $6.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas GCTK's P/E ratio is N/A. In terms of profitability, ALC's ROE is +0.07%, compared to GCTK's ROE of +3.93%. Regarding short-term risk, ALC is less volatile compared to GCTK. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs GMVD Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, ALC is priced at $88.31, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas GMVD's P/E ratio is -0.01. In terms of profitability, ALC's ROE is +0.07%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, ALC is less volatile compared to GMVD. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs GMVDW Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, ALC is priced at $88.31, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas GMVDW's P/E ratio is N/A. In terms of profitability, ALC's ROE is +0.07%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, ALC is less volatile compared to GMVDW. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs AVGR Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, ALC is priced at $88.31, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas AVGR's P/E ratio is -0.05. In terms of profitability, ALC's ROE is +0.07%, compared to AVGR's ROE of -54.25%. Regarding short-term risk, ALC is less volatile compared to AVGR. This indicates potentially lower risk in terms of short-term price fluctuations for ALC.
ALC vs HRC Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, HRC has a market cap of 0. Regarding current trading prices, ALC is priced at $88.31, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas HRC's P/E ratio is 41.92. In terms of profitability, ALC's ROE is +0.07%, compared to HRC's ROE of +0.14%. Regarding short-term risk, ALC is more volatile compared to HRC. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs APR Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, APR has a market cap of 0. Regarding current trading prices, ALC is priced at $88.31, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas APR's P/E ratio is 22.59. In terms of profitability, ALC's ROE is +0.07%, compared to APR's ROE of +9.81%. Regarding short-term risk, ALC is more volatile compared to APR. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs ATRS Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, ALC is priced at $88.31, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas ATRS's P/E ratio is 14.95. In terms of profitability, ALC's ROE is +0.07%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, ALC is more volatile compared to ATRS. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs IIN Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, IIN has a market cap of 0. Regarding current trading prices, ALC is priced at $88.31, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas IIN's P/E ratio is 226.45. In terms of profitability, ALC's ROE is +0.07%, compared to IIN's ROE of -0.00%. Regarding short-term risk, ALC is more volatile compared to IIN. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.
ALC vs LMNX Comparison
ALC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALC stands at 43.1B. In comparison, LMNX has a market cap of 0. Regarding current trading prices, ALC is priced at $88.31, while LMNX trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALC currently has a P/E ratio of 38.72, whereas LMNX's P/E ratio is N/A. In terms of profitability, ALC's ROE is +0.07%, compared to LMNX's ROE of +0.03%. Regarding short-term risk, ALC is more volatile compared to LMNX. This indicates potentially higher risk in terms of short-term price fluctuations for ALC.